The unmet need for COVID-19 treatment in immunocompromised patients

BACKGROUND: Immunocompromised (IC) patients are at increased risk of severe and/or prolonged COVID-19. MAIN TEXT: The recent study by Scaglione et al., addresses the issue of IC outpatients with SARS-CoV-2 infection. Authors describe the real-life use of SARS-CoV-2 antivirals and/or monoclonal antib...

Descripción completa

Detalles Bibliográficos
Autores principales: Alessandra, D’Abramo, Serena, Vita, Emanuele, Nicastri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9742028/
https://www.ncbi.nlm.nih.gov/pubmed/36503419
http://dx.doi.org/10.1186/s12879-022-07918-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9742028/
https://www.ncbi.nlm.nih.gov/pubmed/36503419
http://dx.doi.org/10.1186/s12879-022-07918-x

Ejemplares similares